Posts Tagged ‘fremanezumab’
An Anti-CGRP Antibody Expands the Pediatric Migraine Toolbox: A Look at the Data
A recent randomized controlled trial testing fremanezumab in children and adolescents with episodic migraine showed a reduction in monthly migraine days.
Read MoreNew Clinical Trial Results: Anti-CGRP Treatment Improves Migraine and Comorbid Depression
The first study of its kind shows that fremanezumab could be an effective drug to manage this common comorbidity of migraine.
Read More